Prediction of recurrence of hepatocellular carcinoma after curative hepatectomy using preoperative Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein

Hepatology Research

Volumn 42, Issue 9, 2012, Pages 887-894

  Saito, Yu ^a   Shimada, Mitsuo ^a   Utsunomiya, Tohru ^a   Morine, Yuji ^a   Imura, Satoru ^a   Ikemoto, Tetsuya ^a   Mori, Hiroki ^a   Hanaoka, Jun ^a   Yamada, Shinichiro ^a   Asanoma, Michihito ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Hepatocellular carcinoma; Lens culinaris agglutinin reactive fraction of fetoprotein; Prognostic factor; Recurrence

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; LENS CULINARIS AGGLUTININ A REACTIVE FRACTION OF ALPHA FETOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LENTIL; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; TUMOR DIFFERENTIATION; VASCULAR INVASION;

EID: 84865142951     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01004.x     Document Type: Article

References (20)

1. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
2. Liebman HA, Furie BC, Tong MJ etal. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Eng J Med 1984; 310: 1427-31.
3. Breborowicz J, Mackiewicz A, Breborowicz D etal. Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand J Immunol 1981; 14: 15-20.
4. Taketa K. Alpha-fetoprotein: reevaluation in hepatology. Hepatology 1990; 12: 1420-32.
5. Aoyagi Y, Isemura M, Yosizawa Z etal. Fucosylation of serum alpha-fetoprotein in patients with primary hepatocellular carcinoma. Biochim Biophys Acta 1985; 830: 217-23.
6. Aoyagi Y, Isokawa O, Suda T etal. The fucosylation index of a-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma. Cancer 1998; 83: 2076-82.
7. Kumada T, Nakano S, Takeda I etal. Clinical utility of lens culinaris agglutinin-reactive alphafetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. J Hepatol 1999; 30: 125-30.
8. Song BC, Suh DJ, Yang SH etal. Lens culinaris agglutinin-reactive alpha-fetoprotein as a prognostic marker in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. J Clin Gastroenterol 2002; 35: 398-402.
9. Tada T, Kumada T, Toyoda H etal. Relationship between Lens culinaris agglutinin-reactive a-fetoprotein and pathologic features of hepatocellular carcinoma. Liver Int 2005; 25: 848-53.
10. Tateishi R, Shiina S, Yoshida H etal. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 2006; 40: 1518-27.
11. Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005; 12: 351-5.
12. Liver Cancer Study Group of Japan. Classification of Primary Liver Cancer, 3rd edn. Tokyo: Kanehara, 2010.
13. Torzilli G, Minagawa M, Takayama T etal. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999; 30: 889-93.
14. Shimada M, Yonemura Y, Ijichi H etal. Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value. Transplant Proc 2005; 37: 1177-9.
15. Hayashi K, Kumada T, Nakano S etal. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Am J Gastroenterol 1999; 94: 3028-33.
16. Tamura Y, Igarashi M, Suda T etal. Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment. Dig Dis Sci 2010; 55: 2095-101.
17. Imura S, Ikemoto T, Morine Y etal. Effect of a New adjuvant systemic interferon alpha, 5-fluorouracil and cisplatin on advanced hepatocellular carcinoma with macroscopic portal invasion. Hepatogastroenterology 2008; 55: 615-20.
18. Masuda T, Beppu T, Horino K etal. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma. J Surg Oncol 2010; 102: 490-6.
19. Zhang XF, Lai EC, Kang XY etal. Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection. Ann Surg Oncol 2011; 8: 2218-23.
20. Yamamoto K, Imamura H, Matsuyama Y etal. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC. J Gastroenterol 2010; 45: 1272-82.